🇺🇸 FDA
Pipeline program

Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants.

BLCL-ETN-ANV-01

Phase 1 other active

Quick answer

Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants. for No medical condition is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).

Program details

Company
Laboratorios Tillomed Spain S.L.U
Indication
No medical condition
Phase
Phase 1
Modality
other
Status
active

Clinical trials